<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25622" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Necrotizing Enterocolitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ginglen</surname>
            <given-names>Jacob G.</given-names>
          </name>
          <aff>McLaren Oakland Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Butki</surname>
            <given-names>Nikolai</given-names>
          </name>
          <aff>McLaren Oakland/Michigan State Un/COM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacob Ginglen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nikolai Butki declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25622.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Necrotizing enterocolitis (NEC) is a life-threatening illness almost exclusively affecting neonates with a mortality rate as high as 50 percent. The pathophysiology of NEC is inflammation of the intestine leading to bacterial invasion causing cellular damage and cellular death and necrosis of the colon and intestine. As NEC progresses, it can lead to intestinal perforation causing peritonitis, sepsis, and death. Signs and symptoms of NEC are non-specific and may include poor feeding, vomiting, lethargy, abdominal tenderness. This activity examines the presentation, evaluation, and management of necrotizing enterocolitis and stresses the role of an interprofessional team approach to the care of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the factors associated with increased risk of developing necrotizing enterocolitis.</p></list-item><list-item><p>Describe the presenting features of necrotizing enterocolitis.</p></list-item><list-item><p>Explain how the diagnosis of necrotizing enterocolitis is made.</p></list-item><list-item><p>Review an interprofessional didactic regarding the presenting features, evaluation and management of necrotizing enterocolitis to ensure a high degree of clinician awareness, allowing for improved detection and utilization of up-to-date management strategies to optimize patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25622&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25622">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25622.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Necrotizing enterocolitis (NEC) is a life-threatening illness almost exclusively affecting neonates.&#x000a0; NEC has a mortality rate as high as 50%.&#x000a0; The pathophysiolgy of NEC is inflammation of the intestine leading to bacterial invasion causing cellular damage and&#x000a0;death which causes necrosis of the colon and intestine. As&#x000a0;NEC progresses, it can lead to intestinal perforation causing peritonitis, sepsis, and death.&#x000a0; The signs and symptoms of NEC, poor feeding, vomiting, lethargy, abdominal tenderness, are&#x000a0;nonspecific, so clinicians must remain suspicious when presented with these signs and symptoms in the neonatal population.&#x000a0;<xref ref-type="bibr" rid="article-25622.r1">[1]</xref><xref ref-type="bibr" rid="article-25622.r2">[2]</xref></p>
      </sec>
      <sec id="article-25622.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Necrotizing enterocolitis is caused by bacterial invasion into the intestinal wall. This leads to inflammation and cellular destruction of the wall of the intestine. If unrecognized and untreated, an intestinal perforation may occur, causing spillage of intestinal contents into the peritoneum and resulting in peritonitis. The specific mechanism and cause of this bacterial invasion are not yet understood. In premature neonates, gastrointestinal tract immaturity is believed to play a role in the pathogenesis of necrotizing enterocolitis.</p>
      </sec>
      <sec id="article-25622.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Necrotizing enterocolitis is a disease affecting neonates and is the most common life-threatening emergency affecting the gastrointestinal tract of infants in the neonatal intensive care unit. Necrotizing enterocolitis typically occurs in the second to third week of life. Several risk factors have been identified, but prematurity, low birth weight, and formula feeding have been identified as primary risks<xref ref-type="bibr" rid="article-25622.r2">[2]</xref>. Specifically, high osmotic strength formula feeding has&#x000a0;been implicated as a risk factor.&#x000a0;Genetic factors may also play a role<xref ref-type="bibr" rid="article-25622.r1">[1]</xref>. Incidence worldwide varies between 0.3 to 2.4 infants per 1000 live births. Nearly 70% of these cases occur in premature infants born before 36 weeks gestation. Necrotizing enterocolitis affects 2% to 5% of all premature infants and is responsible for nearly 8% of all NICU admissions. Overall, mortality ranges from 10% to 50%. However, in the most severe cases, involving perforation, peritonitis, and sepsis, mortality approaches 100%.&#x000a0;</p>
        <p>While necrotizing enterocolitis primarily occurs in premature infants, it has been documented in full-term infants. In this population, onset is typically in the first few days of life and is usually associated with a hypoxic event, such as a cyanotic congenital heart defect.</p>
      </sec>
      <sec id="article-25622.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The tissue of the intestinal wall in patients with necrotizing enterocolitis shows inflammation and bacterial invasion. As the disease progresses, tissue shows ischemia, followed by necrosis<xref ref-type="bibr" rid="article-25622.r3">[3]</xref>, and ultimately perforation, which may be either&#x000a0;microperforation or a frank perforation. Microperforation leads to pneumatosis intestinalis, or air within the wall of the intestine. In the event of perforation, the peritoneal cavity becomes contaminated with bacteria and bowel content, leading to peritonitis.</p>
      </sec>
      <sec id="article-25622.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The signs and symptoms of necrotizing enterocolitis are highly variable, nonspecific and subtle<xref ref-type="bibr" rid="article-25622.r4">[4]</xref>. Parents often report decreased activity and fatigue. They may also report gastrointestinal symptoms such as decreased appetite, vomiting, diarrhea, and increasing abdominal girth. Patients may also experience blood in the stool. As the disease progresses, the patient may experience systemic signs related to respiratory failure and circulatory collapse, such as cyanosis and unresponsiveness.</p>
        <p>Physical examination findings may include abdominal distention, abdominal tenderness to palpation, visible intestinal loops, decreased bowel sounds, palpable abdominal mass, and erythema of the abdominal wall. Systemic findings may include respiratory failure, circulatory collapse, and decreased peripheral perfusion.</p>
      </sec>
      <sec id="article-25622.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The single most important test required to&#x000a0;make the diagnosis is an abdominal plain film series including anterior-posterior and left lateral decubitus views. Findings of dilated loops of bowel, pneumatosis intestinalis, and portal venous air is diagnostic for necrotizing enterocolitis. Pneumatosis intestinalis is the visualization of small amounts of air within the bowel wall and is pathognomonic for necrotizing enterocolitis. Portal venous air is not universally present but is a poor prognostic sign when found. Free air in the abdomen may be seen when perforation has occurred.&#x000a0;</p>
        <p>An abdominal radiograph is a valuable tool for tracking the progression of the disease&#x000a0;as well. In most cases, this should be repeated serially every 6 hours until definitive treatment has occurred.&#x000a0;</p>
        <p>Laboratory studies have limited utility and are non-specific. Leukopenia with a white blood cell count below 1500 per microliter is a strong indicator of established sepsis. A comprehensive metabolic panel may show hyponatremia and low serum bicarbonate. Blood cultures are usually negative. A breath hydrogen test may be positive but is rarely performed.</p>
      </sec>
      <sec id="article-25622.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment begins with standard&#x000a0;resuscitation based on the patient's vital signs.&#x000a0; Airway, breathing&#x000a0;and&#x000a0;circulation must be supported in a patient in extremis. Fluid resuscitation is indicated for hypotension. In the event of respiratory failure, the patient may need endotracheal intubation and mechanical ventilation. Pediatric Advanced Life Support guidelines should be followed for resuscitation in circulatory collapse.</p>
        <p>The first intervention when necrotizing enterocolitis is suspected is to stop all enteral feedings and maintain the patient NPO. A nasogastric&#x000a0;tube should be placed for decompression of the dilated bowels. Intravenous antibiotics should be started, with broad-spectrum coverage. The suggested antibiotic regimen includes ampicillin, gentamicin, and either clindamycin or metronidazole. While the patient is NPO, total parenteral nutrition must be provided. If this conservative therapy is effective, infants may resume enteral feedings once signs of infection have resolved. This may take several days to a week in some cases. The presence of normal bowel movements determines the&#x000a0;return of bowel function.</p>
        <p>In infants who have worsening condition or bowel perforation or who do not respond to medical therapy, surgical intervention is indicated. Laparotomy is the standard approach, and surgery is as conservative as possible, with removal only of portions of unquestionably necrotic or perforated intestine in an attempt&#x000a0;to preserve as much intestine as possible<xref ref-type="bibr" rid="article-25622.r5">[5]</xref>. Particular effort is made to preserve the ileocecal valve. A diverting ostomy may be placed and is typically utilized in the infant in shock or extremis or has significant peritonitis. Following recovery, the stoma may be reversed. Primary anastomosis is generally contraindicated due to the risk of ischemia at the anastomosis<xref ref-type="bibr" rid="article-25622.r6">[6]</xref>.&#x000a0;</p>
        <p>Laparotomy may be contraindicated in patients who are extremely&#x000a0;small and ill, as they may not be stable enough to tolerate the surgery<xref ref-type="bibr" rid="article-25622.r7">[7]</xref>. In these patients, if perforation and free air occur, an alternative treatment of insertion of a peritoneal drain may be considered. This can be performed under local anesthesia in the nursery.&#x000a0;</p>
        <p>Future treatments are currently&#x000a0;being studied, including probiotics<xref ref-type="bibr" rid="article-25622.r8">[8]</xref><xref ref-type="bibr" rid="article-25622.r9">[9]</xref><xref ref-type="bibr" rid="article-25622.r10">[10]</xref><xref ref-type="bibr" rid="article-25622.r11">[11]</xref><xref ref-type="bibr" rid="article-25622.r12">[12]</xref>, agents which block the production of nitrous oxide, and even low-dose carbon monoxide.</p>
      </sec>
      <sec id="article-25622.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>With the potentially vague presentation of necrotizing enterocolitis, the differential diagnosis is broad. The symptoms of necrotizing enterocolitis in this population, including nausea and vomiting, may be the result of congenital abnormalities, such as pyloric stenosis, duodenal atresia, tracheoesophageal fistula, gastroschisis, or malrotation with or without midgut volvulus. Infectious causes include gastroenteritis, urinary tract infection, sepsis, meningitis, and pneumonia. Other possibilities include intussusception or testicular torsion. Clinicians&#x000a0;also&#x000a0;must always consider child abuse, including intracranial injury.</p>
      </sec>
      <sec id="article-25622.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for necrotizing enterocolitis depends on the severity of the condition at the time it is recognized and treatment is started. The overall mortality ranges from 10% to 50%. However, for infants with advanced necrotizing enterocolitis, including the full-thickness destruction of the intestinal wall which leads to perforation and peritonitis, mortality approaches 100%.&#x000a0;</p>
      </sec>
      <sec id="article-25622.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications may arise from prolonged hospitalization and treatment. Patients may require prolonged total parenteral nutrition, which may lead to liver failure. Postoperative adhesions and scarring may lead to stricture and obstruction. Other complications include short bowel syndrome, intestinal failure, nutritional deficiencies, and associated defects in growth and development.</p>
      </sec>
      <sec id="article-25622.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Following surgery for necrotizing enterocolitis, infants should receive intravenous antibiotics and total parenteral nutrition for at least 2 weeks. Routine medical care, including monitoring for and correcting electrolyte abnormalities or anemia, should also continue during that time. Ventilatory support should be provided if needed.</p>
      </sec>
      <sec id="article-25622.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Any patient presenting with necrotizing enterocolitis will require a surgical consult. Often, the infant will be admitted to the NICU, requiring a neonatal intensivist consult&#x000a0;as well.&#x000a0;</p>
      </sec>
      <sec id="article-25622.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>In very&#x000a0;low birthweight infants, breastfed infants have a lower incidence of necrotizing enterocolitis. Mothers of these infants should be counseled on the benefits of breastfeeding, particularly regarding its relationship to the development of necrotizing enterocolitis.&#x000a0;</p>
        <p>Antenatal and postnatal conditions which cause diminished intestinal blood flow have been implicated in the increased risk for development of necrotizing enterocolitis. For example, conditions causing placental insufficiency in the antenatal period, such as hypertension, preeclampsia, and cocaine use, may decrease infant intestinal blood flow. For infants born under these conditions, cautious enteral feeding is justified. Postnatal conditions causing similar decreased splanchnic blood flow and therefore an increased risk of necrotizing enterocolitis, include patent ductus arteriosus, other cardiac diseases, or general hypotension and cardiovascular compromise.</p>
      </sec>
      <sec id="article-25622.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Necrotizing enterocolitis is potentially fatal and may present with vague signs and symptoms. Early recognition is paramount. The mainstay of treatment involves cessation of enteral feedings, gastric decompression with a nasogastric tube, intravenous antibiotics, and total parenteral nutrition. The most important diagnostic study is the abdominal plain film, which will show dilated loops of bowel and may show portal venous air or pneumatosis intestinalis, which is pathognomonic. Early surgical consultation is necessary, and many of these patients require NICU admission.</p>
      </sec>
      <sec id="article-25622.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis&#x000a0;and management of necrotizing enterocolitis requires an interprofessional team approach. Diagnosis may&#x000a0;be challenging&#x000a0;given the vague and variable symptoms. The initial evaluation is often by an emergency department physician. Radiologists play a critical role in determining the presence of&#x000a0;pneumatosis intestinalis, which is pathognomonic for NEC. Once the diagnosis is made, the initiation of treatment requires involvement of a large team of professionals. Nurses play a vital role in establishing vascular access for antibiotics, fluid resuscitation, and lab analysis. Early surgical consult is paramount.</p>
        <p>These infants are typically admitted to the Neonatal Intensive Care Unit, with a consult to a neonatal intensivist. Again, nursing staff plays a key role in frequent assessment, as the patient's condition may change quickly. Pharmacists will be involved in the antibiotic selection and dosing for these patients. A nutritionist must be involved&#x000a0;for the initiation of total parenteral nutrition. An interprofessional team approach is vital to improve the outcomes for patients suffering from necrotizing enterocolitis.</p>
      </sec>
      <sec id="article-25622.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25622&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25622">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/necrotizing-enterocolitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25622">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25622/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25622">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25622.s18">
        <fig id="article-25622.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Radiograph of an Infant With Necrotizing Enterocolitis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-sa/3.0/deed.en">RadsWiki.net</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Necrotizing_enterocolitis_202" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25622.s19">
        <fig id="article-25622.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Gross Pathology of Neonatal Necrotizing Enterocolitis. Autopsy&#x000a0;of an infant&#x000a0;with abdominal distention, necrosis, hemorrhage, and peritonitis due to perforation. Edwin P Ewing Jr, MD/Centers for Disease Control and Prevention, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/File:Neonatal_necrotizing_enterocolitis,_gross_pathology_20G0021_lores.jpg">Public Domain</ext-link>, via Wikimedia Commons.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="855_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25622.s20">
        <fig id="article-25622.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Gross Pathology, Neonatal, Necrotizing enterocolitis, Alimentary tract of infant, intestinal necrosis, pneumatosis intestinalis, perforation site shown by arrow Contributed by The Centers for Disease Control and Prevention (CDC)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="20G0022_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25622.s21">
        <title>References</title>
        <ref id="article-25622.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cuna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sampath</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Genetic predisposition to necrotizing enterocolitis in premature infants: Current knowledge, challenges, and future directions.</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>387</fpage>
            <page-range>387-393</page-range>
            <pub-id pub-id-type="pmid">30292709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Afzal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Elberson</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>McLaughlin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Early onset necrotizing enterocolitis (NEC) in premature twins.</article-title>
            <source>J Neonatal Perinatal Med</source>
            <year>2017</year>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>109</fpage>
            <page-range>109-112</page-range>
            <pub-id pub-id-type="pmid">28304317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rugolotto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gruber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Solano</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Chini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gobbo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pecori</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing enterocolitis in a 850 gram infant receiving sorbitol-free sodium polystyrene sulfonate (Kayexalate): clinical and histopathologic findings.</article-title>
            <source>J Perinatol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>247</fpage>
            <page-range>247-9</page-range>
            <pub-id pub-id-type="pmid">17377608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gephart</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wetzel</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Fleiner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Umberger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kirmani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dudding</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Clay</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sauberan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eskenazi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Msowoya</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Wyles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Avenado-Ruiz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reber</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Duchon</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitis.</article-title>
            <source>Matern Health Neonatol Perinatol</source>
            <year>2017</year>
            <volume>3</volume>
            <fpage>23</fpage>
            <pub-id pub-id-type="pmid">29270303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fagenholz</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>de Moya</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Acute inflammatory surgical disease.</article-title>
            <source>Surg Clin North Am</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-30</page-range>
            <pub-id pub-id-type="pmid">24267493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geng</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Early postoperative outcomes of surgery for intestinal perforation in NEC based on intestinal location of disease.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>39</issue>
            <fpage>e12234</fpage>
            <pub-id pub-id-type="pmid">30278493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craven</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Management of a neonate with necrotizing entero-colitis and eight prolapsed stomas in a dehisced wound.</article-title>
            <source>J Wound Ostomy Continence Nurs</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>214</fpage>
            <page-range>214-20</page-range>
            <pub-id pub-id-type="pmid">10476178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sequoia</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.</article-title>
            <source>Am Fam Physician</source>
            <year>2017</year>
            <month>Aug</month>
            <day>01</day>
            <volume>96</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-178</page-range>
            <pub-id pub-id-type="pmid">28762696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bron</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kleerebezem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brummer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cani</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Mercenier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Garcia-R&#x000f3;denas</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Can probiotics modulate human disease by impacting intestinal barrier function?</article-title>
            <source>Br J Nutr</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>117</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-107</page-range>
            <pub-id pub-id-type="pmid">28102115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cruchet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furnes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maruy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hebel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Orsi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rondon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sdepanian</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>X&#x000f3;chihua</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ybarra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zablah</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.</article-title>
            <source>Paediatr Drugs</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-216</page-range>
            <pub-id pub-id-type="pmid">25799959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Versalovic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The human microbiome and probiotics: implications for pediatrics.</article-title>
            <source>Ann Nutr Metab</source>
            <year>2013</year>
            <volume>63 Suppl 2</volume>
            <fpage>42</fpage>
            <page-range>42-52</page-range>
            <pub-id pub-id-type="pmid">24217035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25622.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dylag</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hubalewska-Mazgaj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Surmiak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Szmyd</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brzozowski</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders.</article-title>
            <source>Curr Pharm Des</source>
            <year>2014</year>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>1149</fpage>
            <page-range>1149-55</page-range>
            <pub-id pub-id-type="pmid">23755726</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
